← back to search

Wanqing Xie

Emory University · US
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Osteoarthritis Treatment and Mechanisms, Prostate Cancer Treatment and Research, Wnt/β-catenin signaling in development and cancer, and Protein Degradation and Inhibitors.
h-index
13
citations
432
works
34
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling
Nature Genetics 2025cited by 17position: middledoi
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
Journal of Clinical Investigation 2023cited by 24position: middledoi
Ferroptosis: the vulnerability within a cancer monster
Journal of Clinical Investigation 2023cited by 22position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jindan Yu · Northwestern University3 papers (2023–2025)Jonathan C. Zhao · Northwestern University2 papers (2023–2025)Xiaodong Lü · Broad Institute2 papers (2023–2025)Galina Gritsina · Northwestern University2 papers (2023–2025)Peng Jin · Emory University1 papers (2025–2025)Maha Hussain · University College London1 papers (2023–2023)Irina Cheng · Zhejiang University1 papers (2025–2025)Himisha Beltran · Harvard University1 papers (2023–2023)Nicolas Altemose · Stanford University1 papers (2025–2025)Shivani Agarwal · The Ohio State University Wexner Medical Center1 papers (2023–2023)Zhuoyuan Lin · Southern Medical University1 papers (2023–2023)Ruli Gao · University of Florida1 papers (2025–2025)— · 1 papers (2023–2023)Victor G. Corces · Emory University1 papers (2025–2025)Cheng-Kai Shiau · National Yang Ming Chiao Tung University1 papers (2025–2025)Dong Lin · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2023–2023)Juan Wang · Hebei Medical University1 papers (2025–2025)Yuzhuo Wang · China Agricultural University1 papers (2023–2023)Martin G. Sanda · Emory University1 papers (2025–2025)— · 1 papers (2023–2023)